<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Fresh fetal liver obtained from 3- to 6-month fetus was prepared </plain></SENT>
<SENT sid="1" pm="."><plain>Fetal liver cell suspension (FLC) or fetal liver cell-free suspension (FLCF) were then transfused into two groups of patient of <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>15 of 21 patients of <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> treated with FLC showed reconstitution of haemopoietic function or improvement of peripheral blood pictures, while 27 of 30 patients treated with FLCF showed reconstitution or improvement </plain></SENT>
<SENT sid="3" pm="."><plain>It is verified that there is a stimulating factor for CFU-CM, BFU-E, and CFU-E and also a immunologic stimulant for improving the nonspecific immunologic function of the organism as shown by clinical analysis and experimental study </plain></SENT>
<SENT sid="4" pm="."><plain>It is obvious that the therapeutic effect of FLCF is much better than that of the FLC </plain></SENT>
</text></document>